OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery Process
Maira Rubí Segura Campos, Nidia del Carmen Quintal Bojórquez
Current Cancer Drug Targets (2022) Vol. 23, Iss. 5, pp. 333-345
Closed Access | Times Cited: 21

Showing 21 citing articles:

LPS-Enriched Interaction Drives Spectrum Conversion in Antimicrobial Peptides: Design and Optimization of AA16 Derivatives for Targeting Gram-Negative Bacteria
Wengjuan Xiao, Ruize Sun, Jenny W. H. Lou, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117462-117462
Closed Access

Comprehensive structural and functional analysis of Patuletin as a potent inhibitor of SARS-CoV-2 targeting the RNA-dependent RNA polymerases
Ahmed M. Metwaly, Esmail M. El‐Fakharany, Aisha A. Alsfouk, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138424-138424
Closed Access | Times Cited: 3

Design and Synthesis of some novel Quinazoline-thioacetamide derivatives as anticancer agents, apoptotic inducers, radio-sensitizers, and VEGFR inhibitors
Walid M. Ghorab, Mostafa M. Ghorab
Journal of Molecular Structure (2024) Vol. 1317, pp. 139060-139060
Closed Access | Times Cited: 3

Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2
Ibrahim H. Eissa, Reda G. Yousef, Mostafa A. Asmaey, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101852-101852
Open Access | Times Cited: 9

A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancer
Fang Wang, Xuejiao Yu, Jun Qian, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101077-101077
Open Access | Times Cited: 2

Design, synthesis, in vitro, and in silico studies of new thiadiazol derivatives as promising VEGFR-2 inhibitors and apoptosis inducers
Hazem A. Mahdy, Hazem Elkady, Walid E. Elgammal, et al.
Journal of Molecular Structure (2024) Vol. 1316, pp. 139019-139019
Closed Access | Times Cited: 2

A review of the current trends in computational approaches in drug design and metabolism
Russell B. O. Ouma, Silas M. Ngari, Joshua K. Kibet
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2

Comprehensive molecular docking and dynamic simulations for drug repurposing of clinical drugs against multiple cancer kinase targets
Nilofer Shaikh, R. K Linthoi, K. Venkateswara Swamy, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 16, pp. 7735-7743
Closed Access | Times Cited: 12

Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies
Walid E. Elgammal, Hazem Elkady, Hazem A. Mahdy, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 35853-35876
Open Access | Times Cited: 6

Unlocking Neurodegeneration: Scaffold-Derived Blockers of MAO-B and AChE inspired by Bryophyllum pinnatum: A Structural Exploration
Ezekiel A. Olugbogi, Emmanuel Sunday Omirin, Shola D. Omoseeye, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1

Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2
Ibrahim H. Eissa, Hazem Elkady, Walid E. Elgammal, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138641-138641
Closed Access | Times Cited: 1

Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studies
Hazem Elkady, Walid E. Elgammal, Hazem A. Mahdy, et al.
Computational Biology and Chemistry (2024) Vol. 113, pp. 108221-108221
Closed Access | Times Cited: 1

Investigation of Dual Inhibition of Antibacterial and Antiarthritic Drug Candidates Using Combined Approach Including Molecular Dynamics, Docking and Quantum Chemical Methods
Shabbir Muhammad, Amina Faiz, Shamsa Bibi, et al.
Computational Biology and Chemistry (2024) Vol. 113, pp. 108218-108218
Closed Access | Times Cited: 1

A study on optical properties of various hot drug molecules by 2020
Chun Zhang, Yuting Yang, Xue Yan, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 21, pp. 10046-10060
Closed Access | Times Cited: 4

Cancer pharmacoinformatics: Databases and analytical tools
Pradnya Kamble, Prinsa R. Nagar, Kaushikkumar A. Bhakhar, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access

Molecular Docking in Computer-Aided Drug Discovery: A Powerful Tool for Targeted Therapeutics
Manos C. Vlasiou
BENTHAM SCIENCE PUBLISHERS eBooks (2024), pp. 63-90
Closed Access

Molecular Dynamics in Computer-Aided Drug Discovery: Unveiling Insights into Biomolecular Interactions
Manos C. Vlasiou
BENTHAM SCIENCE PUBLISHERS eBooks (2024), pp. 17-47
Closed Access

Recent advances in anticancer drug discovery: A review
Alemu Tadesse, Kuleni Nemomsa, Frehiwot Beyene
International Journal of Pharmaceutical Chemistry and Analysis (2023) Vol. 10, Iss. 4, pp. 229-236
Open Access

Page 1

Scroll to top